New research presented at APNA 2025 highlights the therapy’s potential for managing a range of mental health conditions, from major depression to ADHD. Once reserved for seasonal affective disorder, ...
Major depressive disorder is a debilitating condition that impacts around 5% of adults worldwide. While doctors commonly prescribe antidepressants to patients, it has several side effects and might ...
NEW YORK, Oct. 2 (UPI) --Bright-light therapy offers major advantages as an addition to treatment with antidepressants for non-seasonal depressive disorders, a new analysis of 11 randomized clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results